RAC 5.76% $1.64 race oncology ltd

Ann: H1 2023 Preclinical and Clinical Programs Update, page-103

  1. 8,417 Posts.
    lightbulb Created with Sketch. 1385
    So how did existing cardioprotective drugs get approved? What was the control arm in their trials?
    They must have found a way to measure cardiotoxicity in the control arm.
    AFAIK this data would be public.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.